Ann Smeets
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
Papers in
-
- Breast Cancer Treatment Studies 52
- Oncology 70
- Cancer Risks and Factors 17
- HER2/EGFR in Cancer Research 15
- Global Cancer Incidence and Screening 10
- Co-authors
- Patrick NevenHans WildiersMarie-Rose ChristiaensFrédéric AmantStefan SunaertSabine DeprezMathieu VandenbulckeRobert Paridaens
- Journals
- Cancer Research (21 papers)Breast Cancer Research and Treatment (14 papers)Annals of Oncology (8 papers)Journal of Clinical Oncology (7 papers)The Breast (6 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Ann Smeets
138 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 983
- Oncology 1.7k
- Genetics 615
- Pulmonary and Respiratory Medicine 1.1k
- Geriatrics and Gerontology 93
Countries citing papers authored by Ann Smeets
This map shows the geographic impact of Ann Smeets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Smeets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Smeets more than expected).
Fields of papers citing papers by Ann Smeets
This network shows the impact of papers produced by Ann Smeets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Smeets. The network helps show where Ann Smeets may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann Smeets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 44 | |
| 11 | A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer Hit paper breakdown → | 2021 | 442 |
| 12 | 2021 | 7 | |
| 13 | 2020 | 44 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 27 | |
| 16 | 2013 | 8 | |
| 17 | 2011 | 298 | |
| 18 | Low 25-hydroxyvitamin d3 serum levels are associated with larger breast tumor size | 2011 | 2 |
| 19 | 2009 | 58 | |
| 20 | Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) +/- trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): Preliminary safety and efficacy data | 2006 | 9 |
About Ann Smeets
Ann Smeets is a scholar working on Cancer Research, Oncology, Geriatrics and Gerontology, Pathology and Forensic Medicine and Anesthesiology and Pain Medicine, having authored 153 papers that have together received 3.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (52 papers), Breast Lesions and Carcinomas (24 papers), Cancer-related cognitive impairment studies (19 papers), Cancer Risks and Factors (17 papers), HER2/EGFR in Cancer Research (15 papers), Glioma Diagnosis and Treatment (13 papers), Global Cancer Incidence and Screening (10 papers) and Estrogen and related hormone effects (10 papers). The work is most often cited by research in Cancer Research (983 citations), Oncology (1.7k citations), Genetics (615 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Geriatrics and Gerontology (93 citations). Ann Smeets has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Patrick Neven, Hans Wildiers, Marie-Rose Christiaens, Frédéric Amant, Stefan Sunaert, Sabine Deprez, Mathieu Vandenbulcke, Robert Paridaens, Giuseppe Floris and Alexander Leemans. Their work appears in journals such as Cancer Research, Breast Cancer Research and Treatment, Annals of Oncology, Journal of Clinical Oncology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.